Related Experiment Videos

Postnatal changes in blood S-adenosylmethionine concentration. Some observations in hyaline membrane disease

Biology of the Neonate
|January 1, 1978
PubMed

Insights

Blood S-adenosylmethionine levels in premature infants with hyaline membrane disease are similar to healthy controls but higher than full-term infants. This suggests cyst(e)ine may be essential for premature babies.

Area of Science:

  • Biochemistry
  • Neonatal Physiology
  • Nutritional Science

Background:

  • S-adenosylmethionine (SAM) is a crucial metabolite involved in various biochemical pathways.
  • Hyaline membrane disease (HMD) is a common respiratory distress condition in premature neonates.
  • Understanding methionine cycle activity and amino acid requirements in premature infants is vital for their development.

Purpose of the Study:

  • To compare blood S-adenosylmethionine concentrations in premature neonates with and without hyaline membrane disease.
  • To investigate the activity of the methionine cycle in premature infants.
  • To provide evidence for the essentiality of cyst(e)ine in premature babies.

Main Methods:

  • Measurement of blood S-adenosylmethionine concentrations.
  • Comparison between premature neonates with HMD, healthy premature neonates, and full-term infants.
  • Analysis of methionine cycle activity and homocysteine sulfur conservation.

Main Results:

  • Blood S-adenosylmethionine levels did not differ between premature neonates with HMD and healthy premature controls.
  • Premature infants exhibited higher S-adenosylmethionine levels than full-term infants.
  • Data suggest active methionine cycling and conservation of homocysteine sulfur in premature infants.

Conclusions:

  • Cyst(e)ine is likely an essential amino acid for premature infants.
  • Methionine metabolism is active in both fetuses and premature neonates.
  • S-adenosylmethionine blood levels in premature infants decrease with age, stabilizing by 2-5 months.

Related Concept Videos